Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 310,547 | 326,441 | 380,860 | 376,778 | 430,874 |
| Receivables | 24,037 | 72,971 | 23,251 | 20,863 | 26,752 |
| Inventories | 18,250 | 12,073 | 15,745 | 14,650 | 11,838 |
| Other current assets | 27,173 | 23,495 | 18,243 | 12,151 | 18,246 |
| TOTAL | $380,007 | $434,980 | $438,099 | $424,442 | $487,710 |
| Non-Current Assets | |||||
| PPE Net | 4,484 | 3,355 | 3,169 | 3,596 | 3,938 |
| Investments And Advances | 29,533 | 7,613 | 34,687 | 36,817 | 38,734 |
| Intangibles | 13,586 | 0 | 14,598 | 14,575 | 13,851 |
| Other Non-Current Assets | 40,062 | 44,911 | 41,206 | 41,033 | 37,653 |
| TOTAL | $87,665 | $55,879 | $93,660 | $96,021 | $94,176 |
| Total Assets | $467,672 | $490,859 | $531,759 | $520,463 | $581,886 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,533 | N/A | 12,469 | 6,573 | 6,549 |
| Accounts payable and accrued liabilities | 8,694 | 12,351 | 11,611 | 13,019 | 16,453 |
| Accrued Expenses | N/A | 68,491 | N/A | N/A | N/A |
| Other current liabilities | 57,412 | N/A | 62,658 | 52,384 | 40,411 |
| TOTAL | $81,086 | $81,939 | $87,573 | $73,684 | $70,774 |
| Non-Current Liabilities | |||||
| Long Term Debt | 97,011 | 109,714 | 96,731 | N/A | N/A |
| Other Non-Current Liabilities | 251,890 | 219,755 | 242,672 | 331,433 | 348,445 |
| TOTAL | $348,901 | $329,469 | $339,403 | $331,433 | $348,445 |
| Total Liabilities | $429,987 | $411,408 | $426,976 | $405,117 | $419,219 |
| Shareholders' Equity | |||||
| Common Shares | 7,312 | 7,312 | 6,699 | 6,445 | 6,445 |
| Retained earnings | -1,140,111 | -1,095,419 | -1,056,528 | -1,005,920 | -941,546 |
| Other shareholders' equity | 163,641 | 2,144 | 147,102 | 133,003 | 115,950 |
| TOTAL | $37,685 | $79,451 | $104,783 | $115,346 | $162,667 |
| Total Liabilities And Equity | $467,672 | $490,859 | $531,759 | $520,463 | $581,886 |